Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Bladder Cancer
Interventions
DRUG

Apaziquone

Apaziquone 4 mg in 40 mL diluent

DRUG

Placebo

Placebo for Double Blind Phase

Trial Locations (47)

10016

University Urology Associates, New York

14618

Urology Associates of Rochester, LLC, Rochester

17604

Urological Associates of Lancaster, Lancaster

19004

Urologic Consultants of Southeastern Pennsylvania, LLP, Bala-Cynwyd

19010

Urology Health Specialists, Bryn Mawr

21401

Anne Arundel Urology, Annapolis

23454

Urology of Virginia, PC, Virginia Beach

23462

Urology of Virginia, PLLC, Virginia Beach

29572

Carolina Urologic Research Center, Myrtle Beach

30060

Urology Enterprises, Marietta

45212

TriState Urologic Services PSC, Inc., Cincinnati

46825

Northeast Indiana Research, LLC, Fort Wayne

47130

First Urology, PSC, Jeffersonville

49546

Spectrum Health Medical Group, Grand Rapids

55418

University of Minnesota, Minneapolis

59802

Five Valleys Urology, Missoula

71106

Regional Urology, LLC, Shreveport

78503

Urology Associates of South Texas, McAllen

80211

The Urology Center of Colorado, Denver

83642

Idaho Urologic Institute, P.A., Meridian

83814

North Idaho Urology, Coeur d'Alene

85032

Precision Trials, LLC, Phoenix

85308

Valley Urologic Associates, Glendale

92653

South Orange County Medical Research Center, Laguna Woods

98043

Integrity Medical Research, LLC, Mountlake Terrace

06762

Connecticut Clinical Research Center, Middlebury

08043

Delaware Valley Urology, LLC - Voorhees, Voorhees Township

08060

Delaware Valley Urology, LLC-Westampton, Woodlane

V8V3N1

G. Steinhoff Clinical Research Pacific Urologic Research, Victoria

B3H 1V7

Queen Elizabeth II Health Science Center, Halifax

L4M7G1

The Male/Female Health and Research Centre - Royal Court Medical Centre, Barrie

N3R4N3

Brantford Urology Research, Brantford

L7N3V2

G. Kenneth Jansz Medicine Professional Corporation, Burlington

L7S1V2

Urology Resource Centre, Burlington

K7L3J7

Kingston General Hospital / Queen's University, Kingston

N2N2B9

Urology Associates, Urologic Medical Research, Kitchener

L3X1W1

Mor Urology, Inc., Newmarket

P1B7K8

Office of Bernard Goldfarb, North Bay

M2J1V1

Stanley Flax Medical Professional Corporation, North York

L6H3P1

The Fe/Male Health Centre, Oakville

L1H7K4

Urotec, Oshawa

M1S4V5

Urology/Male Infertility, Scarborough Village

M4N3M5

Sunnybrook Health Sciences Centre, Toronto

M5G2M9

University Health Network Princess Margaret Hospital, Toronto

H3G1A4

Centre universitaire de sante McGill, Montreal

G1R3S3

Centre Hospitalier Universitaire de Quebec, Québec

J1H5N4

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Spectrum Pharmaceuticals, Inc

INDUSTRY